gastrointestinal and malabsorption disorders (i.e. inflammatory bowel disease, celiac), pancreatitis, chronic kidney or liver disease, cardiac condition that compromises normal function (e.g. mitral valve disease, heart failure), major disability or disorder requiring continuous medical attention.
herb or supplement use that may affect primary outcome.
alcohol use \>3 drinks/day; participation in another trial.
allergies/intolerances to soy; allergies/intolerances to tree nuts, peanuts and seeds (the combination of all 3).
chronic or prescribed use of certain medications including prescription high dose NSAIDs, antacids, warfarin, medications affecting NO synthesis (i.e. sildenafil, organic nitrates, etc.)
acute or chronic infection (e.g. active HIV, TB, COVID-19, chronic inflammatory infections)
chronic inflammatory condition (such as rheumatoid arthritis)
use of antibiotics within 3-months of the study start